John Olson

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Primary Hyperparathyroidism 67%
3. Estrogen Receptors 45%
4. Neoplasms 45%
5. Parathyroid Hormone 43%
6. Aromatase Inhibitors 31%
7. Transcriptome 29%
8. Recurrence 28%
9. Breast 28%
10. Calcium-Sensing Receptors 26%
11. Parathyroidectomy 25%
12. Adjuvant Chemotherapy 24%
13. Gene Expression 23%
14. Neoadjuvant Therapy 22%
15. Therapeutics 20%
16. Genes 19%
17. Hyperparathyroidism 19%
18. Letrozole 18%
19. exemestane 18%
20. Practice Guidelines 17%
21. Surgeons 17%
22. Anastrozole 17%
23. Calcium 17%
24. Segmental Mastectomy 16%
25. Drug Therapy 16%
26. 3-Iodobenzylguanidine 16%
27. Iodine-131 15%
28. Thyroidectomy 15%
29. Thyroid Neoplasms 14%
30. Melanoma 14%
31. Pheochromocytoma 13%
32. Astrocytes 12%
33. Saccharomyces cerevisiae 12%
34. Plasminogen Activator Inhibitor 1 12%
35. GTP-Binding Protein Regulators 12%
36. Diploidy 12%
37. Adenoma 12%
38. Ionizing Radiation 11%
39. Hormones 11%
40. Iodine 11%
41. Proteins 11%
42. Lymph Node Excision 11%
43. Genome 11%
44. Large-Core Needle Biopsy 10%
45. Hyperplasia 10%
46. Mutation 10%
47. Lymph Nodes 10%
48. Costs and Cost Analysis 10%